68

Qingdao NovelBeam Technology Co LtdSHG 688677 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

1.389

Small

Exchange

XSHG - Shanghai Stock Exchange

688677.SS Stock Analysis

68

Uncovered

Qingdao NovelBeam Technology Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

92/100

Moderate score

Market cap $B

1.389

Dividend yield

2.89 %

Shares outstanding

86.98 B

Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 639 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.

View Section: Eyestock Rating